Intracranial atherosclerosis: incidence, diagnosis and treatment.
Intracranial atherosclerosis is considered a cause of approximately 8% of all strokes in the western society. However, its frequency is much higher in Asian countries. In our hospital-based study, among the patients who had angiographic abnormalities, the frequency of intracranial atherosclerosis was approximately 70% far exceeding that of extratracranial atherosclerosis. Symptomatic atherosclerotic diseases were most often found in the middle cerebral artery. Generally, it has been shown that obesity and hyperlipidemia are related to extracranial diseases while advance hypertension is associated with intracranial diseases. However, these results have not always been replicated, and certain genetic factors may be related with the ethnic differences in the location of atherosclerosis. Recent studies using diffusion weighted MRI showed that the main mechanisms of stroke in patients with intracranial atherosclerosis are the branch occlusion, artery to artery embolism and both. The intracranial stenosis, especially symptomatic one, is not a static condition and may progress or regress in a relatively short period of time. Progressive stenosis of intracranial arteries is clearly related to the development of ischemic events. The annual risk of stroke relevant to the stenosed intracranial vessel is approximately 8%. In retrospective studies including ASID, anticoagulation was found to be superior to aspirin in reducing the stroke events. However, a recent prospective study failed to confirm the superiority of anticoagulation over aspirin in patients with intracranial stenosis. Moreover, anticoagulation resulted in excessive central nervous system bleeding as compared to aspirin. Because aspirin alone seems to be insufficient in the prevention of progression of intracranial stenosis, a combination of antiplatelets has been tried. Recently, we found that a combination of aspirin + cilostazol was superior to aspirin monotherapy in the prevention of progression of symptomatic intracranial stenosis. However, further studies are required to find out the best combination of antiplatelets for symptomatic intracranial stenosis. The effect of other atheroma stabilizers such as statins should also be properly evaluated. Angioplasty/stent is another important option for the relatively severe intracranial stenosis. According to previous studies, immediate success rate has reached up to 90%. If patients are carefully selected, and procedures done by experienced hand, angioplasty/stent can be of benefit especially in relatively young patients with proximal, short-segment, severe symptomatic stenosis. However, this procedure is not without complications or long-term re-stenosis. Further studies are required to elucidate the best therapeutic strategy in patients with intracranial atherosclerosis.
Kim
Jong S
JS
Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kang
Dong-Wha
DW
Kwon
Sun U
SU
Circulation. 1995 Aug 1;92(3):657-71
7634481
Stroke. 1995 Jan;26(1):14-20
7839388
Neurology. 1995 Aug;45(8):1488-93
7644046
Arch Neurol. 1990 Oct;47(10):1080-4
2222239
Stroke. 1981 Mar-Apr;12(2):228-9
7233469
Stroke. 2005 Jan;36(1):92-7
15550686
Stroke. 1998 Feb;29(2):433-8
9472886
Am J Cardiol. 2000 Sep 1;86(5):499-503
11009265
N Engl J Med. 2001 Nov 15;345(20):1444-51
11794192
Stroke. 1975 Sep-Oct;6(5):539-42
1179464
Ann Nucl Med. 2004 Feb;18(1):13-21
15072179
Stroke. 2002 Feb;33(2):532-6
11823665
Eur J Neurol. 2005 Mar;12(3):218-22
15693812
N Engl J Med. 2001 Aug 16;345(7):494-502
11519503
Stroke. 2004 Jun;35(6):1375-80
15131312
Stroke. 1993 Jun;24(6):779-86
8506547
Arch Neurol. 2002 Feb;59(2):259-63
11843697
Angiology. 1972 Apr;23(4):228-39
5030559
Stroke. 1996 Nov;27(11):1974-80
8898801
Arch Neurol. 2004 Apr;61(4):514-9
15096399
J Neurol Sci. 1996 Nov;143(1-2):1-13
8981292
Stroke. 2005 Apr;36(4):782-6
15746463
Neuroepidemiology. 2003 Mar-Apr;22(2):106-17
12656117
Neurology. 1989 Sep;39(9):1246-50
2671793
Cerebrovasc Dis. 2003;15(1-2):90-7
12499717
Neurology. 1990 Oct;40(10):1541-5
2215945
Neurology. 2005 Feb 8;64(3):551-2
15699395
N Engl J Med. 1985 Nov 7;313(19):1191-200
2865674
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):847-51
15145998
J Comput Assist Tomogr. 2001 Jul-Aug;25(4):520-8
11473180
Stroke. 2003 Oct;34(10):2463-8
14500938
Neuroepidemiology. 2004 Jan-Apr;23(1-2):23-32
14765534
Korean J Radiol. 2005 Jan-Mar;6(1):1-7
15782013
Vasc Endovascular Surg. 2002 Mar-Apr;36(2):83-91
11951094
AJNR Am J Neuroradiol. 1999 Apr;20(4):553-8
10319958
Stroke. 2001 Dec 1;32(12):2898-904
11739993
Stroke. 1994 Apr;25(4):766-70
8160218
JAMA. 2002 Nov 20;288(19):2411-20
12435254
AJNR Am J Neuroradiol. 2000 Apr;21(4):643-6
10782772
Lancet. 2004 Jul 24-30;364(9431):331-7
15276392
Stroke. 2004 Jun;35(6):1388-92
15105508
Neurology. 2003 Dec 23;61(12):1729-35
14694038
Eur Neurol. 1999;42(3):150-6
10529541
Ann Neurol. 2002 Jul;52(1):74-81
12112050